SCHEMBL6166773

SCHEMBL6166773

O=C1CCc2c1c(C1CC1)nn2CCO

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.52
EPHX2 P34913 1/20 0.34
OPRM1 P35372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168258 0.91 HTT (0.65) HTTEPHX2
SCHEMBL6164339 0.81 HTT (0.34) HTT
SCHEMBL6166391 0.80 HTT (0.42) HTTEPHX2OPRM1
SCHEMBL6164113 0.79 OPRM1 (0.49) HTTOPRM1
SCHEMBL6166242 0.76 HTT (0.42) HTT
SCHEMBL6166246 0.76 HTT (0.42) HTT
SCHEMBL6167721 0.74 HTT (0.48) HTT
SCHEMBL6164169 0.71 HTT (0.48) HTT
SCHEMBL6165167 0.69 HTT (1.00) HTTOPRM1
SCHEMBL6167339 0.68 HTT (0.45) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed